Viking Therapeutics (VKTX), the developer of a promising experimental weight-loss drug, has announced a multi-year partnership with CordenPharma, a leading contract manufacturing firm.
Read more...
Read More Details
Finally We wish PressBee provided you with enough information of ( Viking Therapeutics is getting closer to bringing its Ozempic competitor to market )
Also on site :
- G42 a Mistral AI sa spájajú so zámerom budovať platformy a infraštruktúry umelej inteligencie novej generácie
- Companies turn to AI to navigate Trump tariff turbulence
- Your new sofa could be the first sign tariff inflation is hitting home